Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 1-(2,6-dimethylphenyl)-3-methylamidinourea
2. Lidamidine, Hydrochloride
3. Lidamidine, Monohydrochloride
4. Whr-1142a
1. 66871-56-5
2. Lidamidine [inn]
3. N-(2,6-dimethylphenyl)-n'-(imino(methylamino)methyl)urea
4. 1-(2,6-dimethylphenyl)-3-(n'-methylcarbamimidoyl)urea
5. 2-[({[imino(methylamino)methyl]amino}carbonyl)amino]-1,3-dimethylbenzene
6. Lidamidine (inn)
7. 1-(2,6-dimethylphenyl)-3-(n-methylcarbamimidoyl)urea
8. Q8x04w8418
9. Ncgc00160661-01
10. Urea, N-(2,6-dimethylphenyl)-n'-(imino(methylamino)methyl)-
11. Dsstox_cid_29006
12. Dsstox_rid_83271
13. Dsstox_gsid_49080
14. Lidamidina
15. Lidamidinum
16. Urea, N-(2,6-dimethylphenyl)-n'-[imino(methylamino)methyl]-
17. Urea,n-(2,6-dimethylphenyl)-n'-[imino(methylamino)methyl]-
18. Lidamidinum [inn-latin]
19. Lidamidina [inn-spanish]
20. Cas-66871-56-5
21. Unii-q8x04w8418
22. Lidamidine [mi]
23. Timtec1_004303
24. Lidamidine [who-dd]
25. Schembl122710
26. Chembl448416
27. Dtxsid4049080
28. Chebi:134907
29. Hms1546d13
30. Tox21_113641
31. Mfcd00449519
32. Stk095480
33. Zinc13115357
34. Akos001737102
35. Tox21_113641_1
36. Ms-3109
37. Ncgc00160661-02
38. 1-(2',6'-dimethylphenyl)-3-methylamidinourea
39. 1-(methylamidino)-3-(2,6-xylyl)urea
40. D08126
41. 1-(2', 6'-dimethylphenyl)-3-methylamidinourea
42. Sr-01000308723
43. Sr-01000308723-1
44. Brd-k68693535-001-01-8
45. Q27287122
46. Urea, 1-(2,6-dimethyl)phenyl-3-(n-methylamidino)-
| Molecular Weight | 220.27 g/mol |
|---|---|
| Molecular Formula | C11H16N4O |
| XLogP3 | 1.6 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 2 |
| Rotatable Bond Count | 2 |
| Exact Mass | 220.13241115 g/mol |
| Monoisotopic Mass | 220.13241115 g/mol |
| Topological Polar Surface Area | 79.5 Ų |
| Heavy Atom Count | 16 |
| Formal Charge | 0 |
| Complexity | 267 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Antidiarrheals
Miscellaneous agents found useful in the symptomatic treatment of diarrhea. They have no effect on the agent(s) that cause diarrhea, but merely alleviate the condition. (See all compounds classified as Antidiarrheals.)
Adrenergic Agonists
Drugs that bind to and activate adrenergic receptors. (See all compounds classified as Adrenergic Agonists.)
ABOUT THIS PAGE
A Lidamidine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Lidamidine, including repackagers and relabelers. The FDA regulates Lidamidine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Lidamidine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Lidamidine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Lidamidine supplier is an individual or a company that provides Lidamidine active pharmaceutical ingredient (API) or Lidamidine finished formulations upon request. The Lidamidine suppliers may include Lidamidine API manufacturers, exporters, distributors and traders.
click here to find a list of Lidamidine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Lidamidine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Lidamidine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Lidamidine GMP manufacturer or Lidamidine GMP API supplier for your needs.
A Lidamidine CoA (Certificate of Analysis) is a formal document that attests to Lidamidine's compliance with Lidamidine specifications and serves as a tool for batch-level quality control.
Lidamidine CoA mostly includes findings from lab analyses of a specific batch. For each Lidamidine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Lidamidine may be tested according to a variety of international standards, such as European Pharmacopoeia (Lidamidine EP), Lidamidine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Lidamidine USP).
LOOKING FOR A SUPPLIER?
